239 related articles for article (PubMed ID: 29256167)
1. Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bevacizumab for corneal neovascularization in Stevens-Johnson syndrome.
Yoon HJ; Kim MK; Seo KY; Ueta M; Yoon KC
Int Ophthalmol; 2019 Jan; 39(1):55-62. PubMed ID: 29256167
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization.
You IC; Im SK; Lee SH; Yoon KC
Cornea; 2011 Jan; 30(1):30-3. PubMed ID: 20861729
[TBL] [Abstract][Full Text] [Related]
3. Comparison of photodynamic therapy with two different parameters combined with subconjunctival injection of bevacizumab for corneal neovascularization.
Yin XF; Wu MH; Jin CJ; Zhou SY
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104067. PubMed ID: 38548042
[TBL] [Abstract][Full Text] [Related]
4. [Corneal neovascularisation treatments compared: Subconjunctival bevacizumab injections and/or photodynamic therapy].
Hamdan J; Boulze M; Aziz A; Alessi G; Hoffart L
J Fr Ophtalmol; 2015 Dec; 38(10):924-33. PubMed ID: 26522892
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with verteporfin for corneal neovascularization.
Al-Torbak AA
Middle East Afr J Ophthalmol; 2012; 19(2):185-9. PubMed ID: 22623856
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with verteporfin for corneal neovascularization.
Yoon KC; You IC; Kang IS; Im SK; Ahn JK; Park YG; Ahn KY
Am J Ophthalmol; 2007 Sep; 144(3):390-395. PubMed ID: 17631268
[TBL] [Abstract][Full Text] [Related]
7. Intrastromal bevacizumab in the management of corneal neovascularization: a retrospective review.
Gupta AA; Mammo DA; Page MA
Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):167-173. PubMed ID: 31713747
[TBL] [Abstract][Full Text] [Related]
8. Topical bevacizumab and ocular surface neovascularization in patients with stevens-johnson syndrome.
Uy HS; Chan PS; Ang RE
Cornea; 2008 Jan; 27(1):70-3. PubMed ID: 18245970
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA
Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509
[TBL] [Abstract][Full Text] [Related]
10. Triple therapy for corneal neovascularization: a case report.
Veritti D; Vergallo S; Lanzetta P
Eur J Ophthalmol; 2012; 22 Suppl 7():S126-8. PubMed ID: 21928258
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy (intravitreal bevacizumab plus verteporfin photodynamic therapy) versus intravitreal bevacizumab monotherapy for choroidal neovascularization due to age-related macular degeneration: a 1-year follow-up study.
Saviano S; Leon PE; Mangogna A; Tognetto D
Digit J Ophthalmol; 2016; 22(2):46-53. PubMed ID: 27582675
[TBL] [Abstract][Full Text] [Related]
12. Bilateral response after unilateral subconjunctival bevacizumab injection in a child with Stevens-Johnson syndrome.
Kesarwani S; Sahu SK; Basu S
J AAPOS; 2012 Jun; 16(3):309-11. PubMed ID: 22459106
[TBL] [Abstract][Full Text] [Related]
13. Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin.
Yoon KC; Ahn KY; Lee SE; Kim KK; Im SK; Oh HJ; Jeong IY; Park SW; Park YG; Nah HJ; Im WB
Curr Eye Res; 2006 Mar; 31(3):215-24. PubMed ID: 16531278
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization.
Holzer MP; Solomon KD; Vroman DT; Sandoval HP; Margaron P; Kasper TJ; Crosson CE
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2954-8. PubMed ID: 12824237
[TBL] [Abstract][Full Text] [Related]
15. Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy.
Oh JY; Kim MK; Wee WR
Cornea; 2009 Oct; 28(9):1070-3. PubMed ID: 19724199
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization.
You IC; Kang IS; Lee SH; Yoon KC
Acta Ophthalmol; 2009 Sep; 87(6):653-8. PubMed ID: 19021596
[TBL] [Abstract][Full Text] [Related]
17. Corneal Fine Needle Diathermy With Adjuvant Bevacizumab to Treat Corneal Neovascularization in Children.
Elbaz U; Mireskandari K; Shen C; Ali A
Cornea; 2015 Jul; 34(7):773-7. PubMed ID: 25811720
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy of corneal neovascularization with verteporfin.
Fossarello M; Peiretti E; Zucca I; Serra A
Cornea; 2003 Jul; 22(5):485-8. PubMed ID: 12827058
[TBL] [Abstract][Full Text] [Related]
19. Perilimbal bevacizumab injection for interface neovascularization after deep anterior lamellar keratoplasty.
Foroutan A; Fariba B; Pejman B; Mahmoud J; Khalil GF; Arash EA; Foroutan P
Cornea; 2010 Nov; 29(11):1268-72. PubMed ID: 20802316
[TBL] [Abstract][Full Text] [Related]
20. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.
Lazic R; Gabric N
Ophthalmology; 2007 Jun; 114(6):1179-85. PubMed ID: 17544776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
